Treatment results of radiotherapy for carcinoma of the cervical esophagus

• Published in: Acta oncologica 2006, Vol.45 (8), p.1120-1125
• Main Authors: Yamada, Kazunari, Murakami, Masao, Okamoto, Yoshiaki, Okuno, Yoshishige, Nakajima, Toshifumi, Kusumi, Fusako, Takakuwa, Hiroshi, Matsusue, Satoru
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Esophageal Neoplasms - mortality; Esophageal Neoplasms - pathology; Esophageal Neoplasms - radiotherapy; Female; Humans; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Treatment Outcome
• ISSN: 0284-186X; 1651-226X
• DOI: 10.1080/02841860600609768

The methods and results of treatment for cancer of the cervical esophagus differ from those for cancer of the thoracic esophagus. Our objective was to retrospectively review the outcome for cervical esophageal cancer patients treated with radiotherapy. Twenty-seven patients with carcinoma of the cervical esophagus treated with definitive radiotherapy from 1988 to 2002 were enrolled in the study. Clinical stage (UICC 1997) was stage I in five, II in six, III in 12 and IV in four. Concurrent head and neck malignancy was found in six patients (22%). The mean radiation dose was 66 Gy. Concurrent chemotherapy (cisplatin and 5-fluorouracil) was performed in 23 patients. The actuarial overall survival rates at 1, 3 and 5 years were 55.6%, 37.9% and 37.9%, respectively, with a median survival of 13.9 months. In the patients with stage I, the 3-year and 5-year survival rates were 75% and 75%, respectively. With univariate analysis, only two of the possible prognostic factors were found to actually influence survival: performance status (p < 0.01) and tumor length (p < 0.01). The survival of patients with cervical esophageal cancer remains poor. It is thought that organ preservation is possible by definitive chemoradiation for early cancer.